Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Increasing Prevalence of Multiple Sclerosis in New Zealand.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Comparing statistical methods for removing seasonal variation from vitamin D measurements in case-control studies.
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies.
Recognizing and overcoming potential barriers to oral medications for MS.
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Appendix: clinical evaluation and treatment of transverse myelitis.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Chronic inflammatory demyelinating polyneuropathy with membranous nephropathy.
Increase in multiple sclerosis activity after assisted reproduction technology.
Cortisol awakening response is linked to disease course and progression in multiple sclerosis.
Relapsing MS patients more satisfied with Novartis oral drug Gilenya(TM) than standard injectable therapies, according to new study results at CMSC
Evolution of rapid nerve conduction.
A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.
New clinical insights into combined central and peripheral demyelination (CCPD).
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
Metaboreflex activity in multiple sclerosis patients.
IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis.
Diminished schwann cell repair responses underlie age-associated impaired axonal regeneration.
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy.
Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis.
Pages
« first
‹ previous
…
584
585
586
587
588
589
590
591
592
…
next ›
last »